Jonathan Dabora

Jonathan Dabora is an accomplished biopharmaceutical leader with a strong focus on enterprise value creation and fostering innovation through collaboration across various teams.

His extensive background in portfolio management, market access, and early commercial strategy has consistently driven successful product launches and optimized the performance of established brands.

Jonathan's aspirations include further development as a prominent leader in the expanding biopharmaceutical sector, seeking roles with escalating responsibilities in the development and commercialization of cutting-edge pharmaceutical solutions.

Through his tenure, Jonathan has spearheaded transformative initiatives like the holistic portfolio prioritization for the Cardio-Metabolic Franchise, demonstrating his ability to influence decision-making at strategic levels.

His leadership in the OPEN Planning initiative showcases his commitment to aligning enrollment planning with early launch strategies, enhancing overall product positioning and success.

Acknowledged for his excellence, Jonathan received a global brand best practice award for his contributions to Market Access Marketing, which effectively distinguished products in competitive markets.

Jonathan's versatile skills were evident in his role as the Global Patient Value and Access Director at Takeda Oncology, where he significantly impacted the Hematology Franchise.

With a solid academic foundation that includes an MBA from UCLA Anderson School of Management and a Ph.D. in Biochemistry from the University of California-Berkeley, Jonathan's expertise spans both business and scientific domains.

His experience as the Founder and CEO of a pharmaceutical company underscores his entrepreneurial spirit and strategic acumen in leading initiatives focused on metabolic diseases.

Jonathan's diverse professional journey encompasses roles in top-tier organizations like Novartis Oncology and Fort Mason Capital, where he has consistently delivered exceptional results and contributed to significant investment successes in the life sciences sector.

His passion for innovation and value creation is further exemplified by his experience as a Venture Associate at CW Ventures and Research Fellow at the Fred Hutchinson Cancer Research Center.

Jonathan Dabora's rich background, comprising leadership roles, entrepreneurial ventures, and scholarly achievements, positions him as a versatile and influential figure in the biopharmaceutical landscape.

He continues to strive for excellence and growth, aiming to make a lasting impact on the industry through his leadership and strategic insights.